Pregnane X receptor polymorphisms associated with human diseases
- 28 August 2013
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Targets
- Vol. 17 (10) , 1167-1177
Abstract
Introduction: Pregnane X receptor (PXR) belongs to the nuclear hormone receptor superfamily and is mostly expressed in liver and intestine. PXR is activated by a wide range of compounds, including drugs, and regulates the transcription of numerous metabolic enzymes implicated in cellular response to xenobiotics. Genetic variation in the PXR gene may influence a wide range of physiologic pathways and have widespread effects on the pharmacokinetics of many drugs. In addition, PXR polymorphisms have been associated with both benign and malignant disease states, in terms of disease risk and severity, gene expression and drug clearance. Areas covered: The aim of the present review is to assess the significance of PXR polymorphisms in human diseases and their putative therapeutic perspectives. To this end, all the existing English literature concerning PXR polymorphisms in relation to disease risk and severity, as well as treatment response, is summarized and presented. Expert opinion: The importance of PXR polymorphisms lies both in their prognostic value and their exploitation for improved individualized therapeutic approaches. PXR polymorphisms could be implicated in selective drug targeting leading to PXR modulation. Nevertheless, additional studies are required to fully understand their potential.Keywords
This publication has 84 references indexed in Scilit:
- Hepatic OATP1B Transporters and Nuclear Receptors PXR and CAR: Interplay, Regulation of Drug Disposition Genes, and Single Nucleotide PolymorphismsMolecular Pharmaceutics, 2009
- Structure and Function of the Human Nuclear Xenobiotic Receptor PXRCurrent Drug Metabolism, 2005
- PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activatorsToxicology and Applied Pharmacology, 2004
- The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variantsPharmacogenetics, 2001
- The PXR ligand-binding domain: how to be picky and promiscuous at the same timeTrends in Pharmacological Sciences, 2001
- The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed PromiscuityScience, 2001
- SXR, a novel steroid and xenobioticsensing nuclear receptorGenes & Development, 1998
- Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A inductionProceedings of the National Academy of Sciences, 1998
- The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.Journal of Clinical Investigation, 1998
- An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling PathwayCell, 1998